Evidence map›Paper›PMID 30890149›Full record

ArticleBMC microbiology2019

Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment.

Sónia Gonçalves Pereira, Susana Alarico, Igor Tiago, Diogo Reis, Daniela Nunes-Costa, Olga Cardoso, Ana Maranha, Nuno Empadinhas

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Microorganisms · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Emerging microbes & infections · 2022
    Article
  6. Clinical Characteristics and Antimicrobial Susceptibility ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  7. Identification of Nontuberculous Mycobacteria in Drinking Water in Cali, Colombia.International journal of environmental research and public health · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sónia Gonçalves PereiraCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal.
Susana AlaricoCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal.
Igor TiagoCentre for Functional Ecology (CFE), Department of Life Sciences, University of Coimbra, Coimbra, Portugal.
Diogo ReisCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal.
Daniela Nunes-CostaCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal.
Olga CardosoFaculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
Ana MaranhaCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal. anamaranha@gmail.com.
Nuno EmpadinhasCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal. nuno.empadinhas@uc.pt.ORCID 0000-0001-8938-7560
University of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNontuberculous mycobacteria (NTM) are ubiquitous in nature and recognized agents of opportunistic infection, which is often aggravated by their intrinsic resistance to antimicrobials, poorly defined therapeutic strategies and by the lack of new drugs. However, evaluation of their prevalence in anthropogenic environments and the associated antimicrobial resistance profiles have been neglected. In this work, we sought to determine minimal inhibitory concentrations of 25 antimicrobials against 5 NTM isolates recovered from a tertiary-care hospital surfaces. Antimicrobial susceptibilities of 5 other Corynebacterineae isolated from the same hospital were also determined for their potential clinical relevance.

resultsOur phylogenetic study with each of the NTM isolates confirm they belong to Mycobacterium obuense, Mycobacterium mucogenicum and Mycobacterium paragordonae species, the latter initially misidentified as strains of M. gordonae, a species frequently isolated from patients with NTM disease in Portugal. In contrast to other strains, the M. obuense and M. mucogenicum examined here were resistant to several of the CLSI-recommended drugs, suggestive of multidrug-resistant profiles. Surprisingly, M. obuense was susceptible to vancomycin. Their genomes were sequenced allowing detection of gene erm (erythromycin resistance methylase) in M. obuense, explaining its resistance to clarithromycin. Remarkably, and unlike other strains of the genus, the Corynebacterium isolates were highly resistant to penicillin, ciprofloxacin and linezolid.

conclusionsThis study highlights the importance of implementing effective measures to screen, accurately identify and control viable NTM and closely related bacteria in hospital settings. Our report on the occurrence of rare NTM species with antibiotic susceptibility profiles that are distinct from those of the corresponding Type strains, along with unexpected resistance mechanisms detected seem to suggest that resistance may be more common than previously thought and also a potential threat to frail and otherwise vulnerable inpatients.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsCorynebacteriumCross InfectionEquipment and Supplies, HospitalHumansMicrobial Sensitivity TestsMycobacterium Infections, NontuberculousNontuberculous MycobacteriaPatients' RoomsPhylogenyPortugalTertiary Care CentersAnti-Bacterial AgentsAntimicrobial resistanceCorynebacterineaeMycobacterium mucogenicumMycobacterium obuenseMycobacterium paragordonaeNontuberculous mycobacteria (NTM)

Identifiers

PMID30890149
PMCPMC6425705
OpenAlexW2942482253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.